Data Science, Astellas Pharma Global Development, Inc, Northbrook, Illinois, USA.
Department of Statistics, George Mason University, Fairfax, Virginia, USA.
Pharm Stat. 2024 Nov-Dec;23(6):1166-1180. doi: 10.1002/pst.2427. Epub 2024 Aug 9.
In alignment with the ICH guideline for Good Clinical Practice [ICH E6(R2)], quality tolerance limit (QTL) monitoring has become a standard component of risk-based monitoring of clinical trials by sponsor companies. Parameters that are candidates for QTL monitoring are critical to participant safety and quality of trial results. Breaching the QTL of a given parameter could indicate systematic issues with the trial that could impact participant safety or compromise the reliability of trial results. Methods for QTL monitoring should detect potential QTL breaches as early as possible while limiting the rate of false alarms. Early detection allows for the implementation of remedial actions that can prevent a QTL breach at the end of the trial. We demonstrate that statistically based methods that account for the expected value and variability of the data generating process outperform simple methods based on fixed thresholds with respect to important operating characteristics. We also propose a Bayesian method for QTL monitoring and an extension that allows for the incorporation of partial information, demonstrating its potential to outperform frequentist methods originating from the statistical process control literature.
根据 ICH 指导原则良好临床规范[ICH E6(R2)],质量公差限(QTL)监测已成为赞助商公司基于风险的临床试验监测的标准组成部分。对于 QTL 监测候选的参数对参与者的安全性和试验结果的质量至关重要。违反给定参数的 QTL 可能表明试验中存在系统性问题,这些问题可能影响参与者的安全性或损害试验结果的可靠性。QTL 监测方法应尽早发现潜在的 QTL 突破,同时限制误报率。早期检测允许实施补救措施,以防止试验结束时出现 QTL 突破。我们证明,考虑到数据生成过程的预期值和变异性的基于统计学的方法在重要的操作特性方面优于基于固定阈值的简单方法。我们还提出了一种用于 QTL 监测的贝叶斯方法及其扩展,允许纳入部分信息,证明了其在性能上优于源自统计过程控制文献的频率方法的潜力。